scholarly journals Sleep quality and depressive disorders among priests of the Archdiocese of Katowice

2021 ◽  
Vol 75 ◽  
pp. 85-98
Author(s):  
Agnieszka Oleszko ◽  
Jadwiga Jośko-Ochojska ◽  
Jerzy Smoleń ◽  
Rafał Śpiewak

WstępPrzewlekły stres wpływa na jakość snu oraz wywołuje symptomy depresji u osób aktywnych zawodowo. Posługa kapłańska, ze względu na swą specyfikę, może generować przewlekły stres, wpływać na jakość snu i wywoływać depresję. Celem pracy jest analiza obciążeń zawodowych księży katolickich, ocena jakości snu i rozpowszechnienia zaburzeń depresyjnych w tej grupie oraz wyodrębnienie czynników mających wpływ na ich występowanie u duchownych.Materiał i metodyZbadano 223 księży diecezjalnych i zakonnych Archidiecezji Katowickiej. W badaniu zastosowano autorski, poddany walidacji kwestionariusz, skalę depresji Becka (Beck Depression Inventory – BDI-II) oraz Skalę Jakości Snu (SJS).WynikiCzynnikami wywołującymi najsilniejszy stres u badanych księży były relacje z przełożonymi (68,2%) oraz zmiana parafii (66,8%). Najczęstszym z subiektywnie odczuwanych przez respondentów negatywnych stanów podczas całej dotychczasowej służby kapłańskiej było przemęczenie (92,4%). W badanej grupie u 20,2% księży występowała pogorszona jakość snu, a zaburzenia depresyjne o różnym stopniu nasilenia wykazano u 27,4% badanych. Wykazano zależność jakości snu oraz depresji od nasilenia stresu związanego ze zmianą parafii, relacjami z przełożonymi, celibatem oraz życiem w pojedynkę.WnioskiKsięża niechętnie poddają się badaniu kwestionariuszowemu dotyczącemu stanu zdrowia psychicznego, jednocześnie stanowią grupę wysokiego ryzyka występowania zaburzeń snu i zaburzeń depresyjnych. Im niższa była jakość snu, tym wyższe wskaźniki zaburzeń depresyjnych. Perfekcjonizm, nadmierne zaangażowanie, poczucie niezrozumienia, potrzeba uznania i wysoka wrażliwość interpersonalna sprzyjały nasileniu symptomów depresji w badanej grupie.

2020 ◽  
Vol 79 (Suppl 1) ◽  
pp. 1578.2-1578
Author(s):  
N. Gokcen ◽  
A. Komac ◽  
F. Tuncer ◽  
A. Yazici ◽  
A. Cefle

Background:Sleep disturbances have been described in Systemic Sclerosis (SSc). Confounding factors related to sleep quality are also investigated. Although sleep hygiene plays an important role in sleep quality, as far as we know, there are not enough data to show the effect of sleep hygiene on sleep quality of SSc.Objectives:To investigate sleep hygiene, its impact on sleep quality, and its association with demographic-clinical factors in patients with SSc, rheumatoid arthritis (RA), and healthy controls.Methods:The study was designed as cross-sectional. Forty-nine patients with SSc who fulfilled the 2013 ACR/EULAR classification criteria for SSc, 66 patients with RA who fulfilled 1987 revised classification criteria, and 30 healthy controls were included in the study. All participants were female. Demographic and clinical variables were documented. Disease activity index of both SSc and RA was calculated. SSc patients were assessed by questionnaires including Short Form 36 (SF-36), The Health Assessment Questionnaire Disability Index (HAQ-DI), Beck Anxiety and Beck Depression Inventory, Pittsburg Sleep Quality Index (PSQI), Sleep Hygiene Index (SHI). Additionally, RA patients and healthy controls were estimated by HAQ-DI, Beck Anxiety and Beck Depression Inventory, PSQI, and SHI. Logistic regression analysis was used to determine the predictors of sleep quality.Results:Preliminary results of the study were given. The baseline demographics were similar among groups. When comparing groups according to HAQ-DI, Beck Anxiety and Beck Depression Inventory, PSQI, and SHI, we found higher scores in SSc and RA rather than healthy controls (p<0.001, p=0.001, p=0.001, p<0.001, p=0.003; respectively). While depression and sleep hygiene were determined as the risk factors of sleep quality in SSc in univariate analysis, depression (OR=1.380, 95%CI: 1.065−1.784, p=0.015) and sleep hygiene (OR=1.201, 95%CI: 1.003−1.439, p=0.046) were also found in multivariate logistic model. In RA patients, while health status, depression, and anxiety were found as risk factors according to the univariate analysis, depression (OR=1.120, 95%CI: 1.006−1.245, p=0.038) was the only factor according to multivariate logistic model (Table).Conclusion:Although depression is a well-known clinical variable impacting on sleep quality, sleep hygiene should also be kept in mind as a confounding factor.References:[1]Milette K, Hudson M, Körner A, et al. Sleep disturbances in systemic sclerosis: evidence for the role of gastrointestinal symptoms, pain and pruritus. Rheumatology (Oxford). 2013 Sep;52(9):1715-20.[2]Sariyildiz MA, Batmaz I, Budulgan M, et al. Sleep quality in patients with systemic sclerosis: relationship between the clinical variables, depressive symptoms, functional status, and the quality of life. Rheumatol Int. 2013 Aug;33(8):1973-9.TableUnivariate logistic regression analysis of clinical variables to assess predictors of sleep qualitySystemic sclerosisRheumatoid arthritisOR (95% CI)pOR (95% CI)pHAQ-DI1.019 (0.882−1.177)0.8011.089 (1.011−1.173)0.025BDI score1.293 (1.082−1.547)0.0051.129 (1.036−1.230)0.006BAI score1.080 (0.997−1.169)0.0591.122 (1.038−1.214)0.004SHI1.200 (1.060−1.357)0.0041.048 (0.965−1.137)0.264Disease activitya0.707 (0.439−1.138)0.1531.446 (0.839−2.492)0.185aDisease activity was calculated by Valentini disease activity index for SSc and DAS28-CRP for RA.Disclosure of Interests:None declared


2002 ◽  
Vol 17 (4) ◽  
pp. 222-226 ◽  
Author(s):  
R. Coelho ◽  
A. Martins ◽  
H. Barros

SummaryPurposeDepressive disorders (DD) in adolescence are often misdiagnosed and under-recognised. A major clinical problem regards the high rate of co-morbidity with other disorders, namely substance abuse. The aim of this study was to assess the discriminative power of the Beck Depression Inventory II (BDI-II) to characterise specific social–demographic variables related to DD in adolescence.MethodsA Portuguese version of the BDI-II and a social–demographic questionnaire were administered to 775 Portuguese adolescents (312 males, 463 females; mean age: 16.9 years); 83 adolescents performed a clinical interview following DSM-IV criteria.ResultsMean BDI-II Portuguese version (BDI-II-P) total score was 10.31 (standard deviation: 8.4), with females reporting more depressive symptoms than males (P < 0.001). Low academic achievement, sleep disturbances, and alcohol consumption were consistently associated with depressive symptoms for both genders. Higher tobacco consumption was significantly associated with depressive symptoms in females. Familial factors did not appear to be associated with depressive symptoms in males. However, a higher frequency of siblings, having separated parents as well as a more extreme perception of the mother's educational style were consistently associated with depressive symptoms in females.ConclusionThe BDI-II-P showed discriminative power to characterise social–demographic variables related to DD especially in adolescent females.


SLEEP ◽  
2021 ◽  
Author(s):  
Yijia Zhang ◽  
Cheng Chen ◽  
Liping Lu ◽  
Kristen L Knutson ◽  
Mercedes R Carnethon ◽  
...  

Abstract Study Objectives As an antagonist of calcium (Ca), magnesium (Mg) has been implicated in the regulation of sleep. We aimed to examine the longitudinal associations of Mg intake and Ca-to-Mg intake ratio (Ca:Mg) with sleep quality and duration. Methods The study sample consisted of 3,964 participants from the Coronary Artery Risk Development in Young Adults (CARDIA) study. Dietary and supplementary intake of Mg were obtained using the CARDIA Dietary History at baseline (1985–1986), exam years 7 and 20. Self-reported sleep outcomes were measured at years 15 and 20. Sleep quality was rating from 1 (very good) to 5 (very bad). We categorized sleep duration to &lt;7, 7–9, and &gt;9 h. Generalized estimating equation was used to examine the associations of interest as repeated measures at the two time points. Results After adjustment for potential confounders, Mg intake was borderline associated with better sleep quality [highest quartile (Q4) vs. intake quartile (Q1): odds ratio (OR) = 1.23; 95% CI = 0.999, 1.50, ptrend = 0.051]. Participants in Q4 were also less likely to have short sleep (&lt;7 h) compared to those in Q1 (OR = 0.64; 95% CI = 0.51, 0.81, ptrend = 0.012). The observed association with short sleep persisted among participants without depressive disorders (Q4 vs. Q1: OR = 0.64; 95% CI = 0.49, 0.82, ptrend &lt; 0.001), but not among individuals with depressive disorder. Ca:Mg was not associated with either outcomes, regardless of depression status. Conclusions Mg intake was associated with both sleep outcomes in this longitudinal analysis. Randomized controlled trials with objective measures of sleep are warranted to establish the potential causal inference.


Acta Medica ◽  
2021 ◽  
pp. 1-7
Author(s):  
İzzet Fidancı ◽  
Hilal Aksoy ◽  
Duygu Ayhan Başer ◽  
Duygu Yengil Taci ◽  
Mustafa Cankurtaran

Objective: The aim of this study is to examine factors that can affect revanchist behavior such as emotional state and sleep quality, and to evaluate the relationship between them. Materials and Methods: 461 individuals at the age of 18 and above who referred to our polyclinic for any reason, and agreed to participate were included in the study via conducting a survey after their written consents were obtained. A survey that consisted of socio-demographic information in the first section, and “the Vengeance Scale”, “the Pittsburgh Sleep Quality Index”, “the State-Trait Anxiety Inventory” and “Beck Depression Inventory” in the second section was applied to the participants. The data were analyzed with IBM SPSS V23. Results: 52.7% of the participants were male and 47.3% were female. The mean age of the study group was 37.4 ± 11.2 years. 51.4% of the participants had severe depression according to the Beck Depression Inventory, while 20.4% had moderate, 16.3% had minimal and 11.9% had mild depression. The median value of the revanchist behavior levels did not differ according to gender (p=0.257). The median value of the revanchist behavior levels in males were 82, while it was 75 in female participants. The median value of the revanchist behavior levels did not differ according to the educational background (p=0.727). A statistically significant relationship was not found between revanchist behavior levels and age, state anxiety, trait anxiety, Beck depression point and PSQI (p>0.05). Conclusion: The absence of a significant relationship between revenge behavior and age, anxiety level, depression and sleep quality will help us to improve the quality of life of societies rather than personal psychological characteristics, and this behavior level that can also cause violence will be minimized.


2006 ◽  
Vol 28 (2) ◽  
pp. 97-103 ◽  
Author(s):  
Marco Aurélio Cigognini ◽  
Letícia Maria Furlanetto

OBJECTIVE: To determine the point prevalence of depressive disorders in medical inpatients, to identify related sociodemographic and medical factors and to evaluate the psychotropic treatment given. METHOD: A cross-sectional study identifying the prevalence of depressive disorders and related factors combined with a prospective longitudinal study evaluating the psychopharmacological treatment were conducted. Medical inpatients, aged 18 years or older, presenting suitability to be interviewed and giving written informed consent were selected. The sample was composed of 125 subjects. The following instruments were used: a sociodemographic questionnaire; the Mini International Neuropsychiatric Interview; and the Beck Depression Inventory. Data related to medical, personal and family histories of psychiatric disorders and psychotropic use were collected by interview and from patient charts. The study took place at the Hospital Santa Isabel, in Blumenau, located in the state of Santa Catarina, Brazil, from January to July of 2002. RESULTS: The prevalence of depressive disorders was 26%. The factors that correlated with depressive disorders were being female, having an income lower than 3 times the minimum wage, having a personal history of depressive disorders, using psychotropic drugs, scoring higher than 13 on the Beck Depression Inventory and having been referred for a psychiatric consultation (p < 0.05). Only 43.8% of the individuals with depressive disorders received antidepressants. Most of the depressed patients were being treated with benzodiazepines (62.5%). The most frequently prescribed drugs were diazepam and fluoxetine. CONCLUSIONS: Approximately one-quarter of the medical inpatients had depressive disorders. However, antidepressants were prescribed for less than half of them. Women with a history of depression, using benzodiazepines and having a low income presented significantly higher rates of depressive disorders. Physicians should suspect depression in patients presenting such characteristics.


2015 ◽  
Vol 18 (7) ◽  
pp. A707 ◽  
Author(s):  
T Grochtdreis ◽  
C Brettschneider ◽  
A Hajek ◽  
K Schierz ◽  
J Hoyer ◽  
...  

2003 ◽  
Vol 93 (2) ◽  
pp. 507-512 ◽  
Author(s):  
Roberta Ball ◽  
Robert A. Steer

The Beck Depression Inventory-II, published in 1996, was administered to 100 adult outpatients (Age M = 43.1 yr., SD = 15.6) who were diagnosed with a recurrent-episode Major Depressive Disorder and 100 outpatients (Age M = 42.8 yr., SD = 15.7) who were diagnosed with a Dysthymic Disorder. Each diagnostic group was composed of 50 men and 50 women who did not have a comorbid depressive disorder. The mean Beck Depression Inventory-II total score and the mean number of symptoms endorsed by the outpatients with a Major Depressive Disorder were significantly (ps < .001) higher than those for outpatients with a Dysthymic Disorder. The usefulness of the Beck Depression Inventory–II was discussed in helping clinicians discriminate between these two unipolar disorders.


2018 ◽  
Vol 33 (3) ◽  
pp. 36-45 ◽  
Author(s):  
T. M. Poponina ◽  
K. I. Gunderina ◽  
Yu. S. Poponina ◽  
M. V. Soldatenko

Aim: to study the changes in heart rate variability (HRV) in patients with anxiety and depressive disorders who suffered acute coronary syndrome (ACS) and to determine the effects of antidepressant agomelatine on HRV and sleep quality during six-month follow up.Material and Methods. The study included 54 people with ACS, anxiety, and depressive disorders. Patients were randomly assigned to two groups. Antidepressant agomelatine 25 mg/day was administered to patients of group 1 in addition to standard therapy for ACS; group 2 received placebo. Twenty four-hour Holter ECG monitoring, HRV study, mental status monitoring, and sleep quality assessment were performed during hospitalization and at six-month follow up.Results. Patients of both groups had clinically significant anxiety, subclinical depression, and insomnia of varying severity. According to Holter monitoring data, all patients had decline in HRV parameters. After six months, anxiety and depression significantly improved in patients administered with agomelatine; these patients had sleep normalization and improved HRV. The comparison group did not have similar changes.Conclusion. Additional administration of agomelatine 25 mg/day to patients with anxiety and depressive disorders after ACS resulted in improvement of mental status, heart rate variability, and sleep quality. Due to the absence of pro-arrhythmogenic effects, administration of agomelatine allows to correct anxiety-depressive disorders in patients with ACS.


Sign in / Sign up

Export Citation Format

Share Document